Drug intelligence / Profile preview

iSCLife X-Arouse+

Development stage
Preclinical
Lead developer
Sclnow Biotechnology
Modality
Stem Cell Therapies → Cell Therapies
01

Overview

iSCLife X-Arouse+ is a stem cell-based anti-aging and regenerative therapy developed by Sclnow Biotechnology. The product is formulated with umbilical cord mesenchymal stem cells (UC-MSCs) as the primary active ingredient, supplemented with cell growth factors, epidermal growth factor, fibrin glue, and other stem cell activating factors. It is designed to activate dormant stem cell populations throughout the body to replace degenerated or aging tissue cells, thereby restoring organ and tissue function. The therapy works through the regenerative and paracrine properties of mesenchymal stem cells, which promote immunomodulation, enhance micro-circulation, and facilitate cellular communication. It is intended for applications in anti-aging, immune regulation, and disease rehabilitation.

Brand names
iSCLife X-Arouse+iSCLife X-Arouse
Other names
iSCLife X-Arouse-Sclnow Biotechnology-cell therapy-stem cell therapy-Anti-aging-immune regulation-disease rehabilitation

Beyond the preview

Go deeper on iSCLife X-Arouse+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iSCLife X-Arouse+.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call